Texas 2021 - 87th Regular

Texas House Bill HB3042 Latest Draft

Bill / Comm Sub Version Filed 05/04/2021

                            87R6788 RDS-F
 By: Patterson, Shine, Ordaz Perez, Collier, H.B. No. 3042
 et al.


 A BILL TO BE ENTITLED
 AN ACT
 relating to the adoption and review of certain workers'
 compensation guidelines, protocols, and formulary.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 413.011, Labor Code, is amended by
 adding Subsection (j) to read as follows:
 (j)  The commissioner by rule may at any time amend or
 replace the treatment guidelines, return-to-work guidelines, or
 individual treatment protocols adopted under Subsection (e) or the
 formulary adopted as described by Section 408.028(b) to ensure that
 the guidelines, protocols, and formulary are current and comply
 with the requirements of this section.
 SECTION 2.  (a) Not later than July 1, 2022, the
 commissioner of workers' compensation shall contract with an
 independent entity to conduct a comparative evaluation of the
 treatment guidelines, return-to-work guidelines, and individual
 treatment protocols adopted by the commissioner under Section
 413.011(e), Labor Code, and the formulary adopted by the
 commissioner as described by Section 408.028(b), Labor Code, and
 report the findings of the evaluation to the commissioner.
 (b)  The commissioner of workers' compensation shall ensure
 that the entity conducting the evaluation under Subsection (a) of
 this section does not have a conflict of interest that would
 adversely impact the entity's independence and impartiality,
 including any financial interest in a developer or publisher of any
 guideline considered in the evaluation. The entity conducting the
 evaluation may not participate in the development of any guideline
 considered in the evaluation.
 (c)  Based on the results of the comparative evaluation
 conducted under Subsection (a) of this section, the commissioner of
 workers' compensation shall determine whether the treatment
 guidelines, return-to-work guidelines, or individual treatment
 protocols adopted by the commissioner under Section 413.011(e),
 Labor Code, or the formulary adopted by the commissioner as
 described by Section 408.028(b), Labor Code, should be amended.
 SECTION 3.  This Act takes effect September 1, 2021.